1. Home
  2. ABEO vs NC Comparison

ABEO vs NC Comparison

Compare ABEO & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • NC
  • Stock Information
  • Founded
  • ABEO 1974
  • NC 1913
  • Country
  • ABEO United States
  • NC United States
  • Employees
  • ABEO N/A
  • NC N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • NC Coal Mining
  • Sector
  • ABEO Health Care
  • NC Energy
  • Exchange
  • ABEO Nasdaq
  • NC Nasdaq
  • Market Cap
  • ABEO 256.9M
  • NC 247.6M
  • IPO Year
  • ABEO 1980
  • NC N/A
  • Fundamental
  • Price
  • ABEO $5.93
  • NC $38.73
  • Analyst Decision
  • ABEO Strong Buy
  • NC
  • Analyst Count
  • ABEO 6
  • NC 0
  • Target Price
  • ABEO $18.00
  • NC N/A
  • AVG Volume (30 Days)
  • ABEO 870.0K
  • NC 7.9K
  • Earning Date
  • ABEO 08-11-2025
  • NC 08-06-2025
  • Dividend Yield
  • ABEO N/A
  • NC 2.61%
  • EPS Growth
  • ABEO N/A
  • NC N/A
  • EPS
  • ABEO N/A
  • NC 4.61
  • Revenue
  • ABEO N/A
  • NC $249,990,000.00
  • Revenue This Year
  • ABEO N/A
  • NC N/A
  • Revenue Next Year
  • ABEO $323.51
  • NC N/A
  • P/E Ratio
  • ABEO N/A
  • NC $8.50
  • Revenue Growth
  • ABEO N/A
  • NC 14.71
  • 52 Week Low
  • ABEO $3.93
  • NC $25.19
  • 52 Week High
  • ABEO $7.32
  • NC $39.65
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 45.53
  • NC 61.44
  • Support Level
  • ABEO $6.10
  • NC $36.58
  • Resistance Level
  • ABEO $6.24
  • NC $39.44
  • Average True Range (ATR)
  • ABEO 0.29
  • NC 1.20
  • MACD
  • ABEO -0.09
  • NC 0.21
  • Stochastic Oscillator
  • ABEO 4.26
  • NC 80.59

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: